Cargando…

Characteristics of ABO Antibodies in Group O Malaysian Blood Donors

BACKGROUND: Haemolytic transfusion reactions (HTRs) due to anti-A and anti-B antibodies in Group O blood products are rare but potentially fatal. This study aimed to identify the prevalence of high ABO antibody titre and the immunoglobulin (Ig) classes (IgM only or with IgG) and the prevalence of ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Saidin, Nur Ilyia Syazwani, Noor, Noor Haslina Mohd, Yusoff, Shafini Mohamed, Sauli, Mohd Shafiq
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Penerbit Universiti Sains Malaysia 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467587/
https://www.ncbi.nlm.nih.gov/pubmed/37655148
http://dx.doi.org/10.21315/mjms2023.30.4.6
_version_ 1785099133462249472
author Saidin, Nur Ilyia Syazwani
Noor, Noor Haslina Mohd
Yusoff, Shafini Mohamed
Sauli, Mohd Shafiq
author_facet Saidin, Nur Ilyia Syazwani
Noor, Noor Haslina Mohd
Yusoff, Shafini Mohamed
Sauli, Mohd Shafiq
author_sort Saidin, Nur Ilyia Syazwani
collection PubMed
description BACKGROUND: Haemolytic transfusion reactions (HTRs) due to anti-A and anti-B antibodies in Group O blood products are rare but potentially fatal. This study aimed to identify the prevalence of high ABO antibody titre and the immunoglobulin (Ig) classes (IgM only or with IgG) and the prevalence of haemolysin antibodies in Group O blood donors. METHODS: Plasma from Group O blood donors was tested by using antibody titration at room temperature. Titres ≥ 64 were considered high. The plasma was treated with 0.01 M dithiothreitol (DTT) to determine the presence of IgG antibodies and titre. IgG titres ≥ 64 were considered high. Tests for haemolysis were conducted by mixing the plasma with 3% fresh A1 and B cell suspensions and incubating at 37 °C. The haemolysis was observed macroscopically. RESULTS: Of 311 donors, 238 (76.5%) showed high anti-A and/or anti-B antibody titres. The highest antibody titre obtained was 256. Female and younger donors (< 40 years old) had higher anti-A and anti-B titres. The anti-B titre showed an association with gender (P < 0.001), and was high in female donors (77.8%). Males aged over 50 years old were found to have low mean titre antibodies. Most donors had both IgM and IgG ABO antibodies. The prevalence of haemolysins in our population was 3.5%. CONCLUSION: Most of our O blood donors had a high ABO antibody titre but a low prevalence of haemolysins. Males aged over 50 years old are the best O donors for preventing HTRs, particularly when mismatch transfusion is required. We recommend a transfusion unit screen for ABO antibody titre in younger female donors (< 40 years old), to prevent the transfusion of high titre O blood products into non-O recipients.
format Online
Article
Text
id pubmed-10467587
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Penerbit Universiti Sains Malaysia
record_format MEDLINE/PubMed
spelling pubmed-104675872023-08-31 Characteristics of ABO Antibodies in Group O Malaysian Blood Donors Saidin, Nur Ilyia Syazwani Noor, Noor Haslina Mohd Yusoff, Shafini Mohamed Sauli, Mohd Shafiq Malays J Med Sci Original Article BACKGROUND: Haemolytic transfusion reactions (HTRs) due to anti-A and anti-B antibodies in Group O blood products are rare but potentially fatal. This study aimed to identify the prevalence of high ABO antibody titre and the immunoglobulin (Ig) classes (IgM only or with IgG) and the prevalence of haemolysin antibodies in Group O blood donors. METHODS: Plasma from Group O blood donors was tested by using antibody titration at room temperature. Titres ≥ 64 were considered high. The plasma was treated with 0.01 M dithiothreitol (DTT) to determine the presence of IgG antibodies and titre. IgG titres ≥ 64 were considered high. Tests for haemolysis were conducted by mixing the plasma with 3% fresh A1 and B cell suspensions and incubating at 37 °C. The haemolysis was observed macroscopically. RESULTS: Of 311 donors, 238 (76.5%) showed high anti-A and/or anti-B antibody titres. The highest antibody titre obtained was 256. Female and younger donors (< 40 years old) had higher anti-A and anti-B titres. The anti-B titre showed an association with gender (P < 0.001), and was high in female donors (77.8%). Males aged over 50 years old were found to have low mean titre antibodies. Most donors had both IgM and IgG ABO antibodies. The prevalence of haemolysins in our population was 3.5%. CONCLUSION: Most of our O blood donors had a high ABO antibody titre but a low prevalence of haemolysins. Males aged over 50 years old are the best O donors for preventing HTRs, particularly when mismatch transfusion is required. We recommend a transfusion unit screen for ABO antibody titre in younger female donors (< 40 years old), to prevent the transfusion of high titre O blood products into non-O recipients. Penerbit Universiti Sains Malaysia 2023-08 2023-08-24 /pmc/articles/PMC10467587/ /pubmed/37655148 http://dx.doi.org/10.21315/mjms2023.30.4.6 Text en © Penerbit Universiti Sains Malaysia, 2023 https://creativecommons.org/licenses/by/4.0/This work is licensed under the terms of the Creative Commons Attribution (CC BY) (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Original Article
Saidin, Nur Ilyia Syazwani
Noor, Noor Haslina Mohd
Yusoff, Shafini Mohamed
Sauli, Mohd Shafiq
Characteristics of ABO Antibodies in Group O Malaysian Blood Donors
title Characteristics of ABO Antibodies in Group O Malaysian Blood Donors
title_full Characteristics of ABO Antibodies in Group O Malaysian Blood Donors
title_fullStr Characteristics of ABO Antibodies in Group O Malaysian Blood Donors
title_full_unstemmed Characteristics of ABO Antibodies in Group O Malaysian Blood Donors
title_short Characteristics of ABO Antibodies in Group O Malaysian Blood Donors
title_sort characteristics of abo antibodies in group o malaysian blood donors
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467587/
https://www.ncbi.nlm.nih.gov/pubmed/37655148
http://dx.doi.org/10.21315/mjms2023.30.4.6
work_keys_str_mv AT saidinnurilyiasyazwani characteristicsofaboantibodiesingroupomalaysianblooddonors
AT noornoorhaslinamohd characteristicsofaboantibodiesingroupomalaysianblooddonors
AT yusoffshafinimohamed characteristicsofaboantibodiesingroupomalaysianblooddonors
AT saulimohdshafiq characteristicsofaboantibodiesingroupomalaysianblooddonors